Decentralized Clinical Trial Innovation and Direct-to-Patient Regulations – It’s Time to Catch Up!
Reading Time: 4 minutes Clinical trials have seen a significant shift towards decentralization over the past decade; this involves more aspects of a trial being brought to the patient’s environment, rather than the tradition of bringing patients to a trial site. One aspect of decentralization and improving the patient experience is by delivering medication and treatments to the patient’s […]
Article
